Exposure to North Dakota road material may increase risk of lung cancer

December 09, 2010

New data shows that people exposed to the mineral erionite found in the gravel of road materials in North Dakota may be at significantly increased risk of developing mesothelioma, a type of lung cancer most often associated with asbestos exposure, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and The University of Chicago.

Erionite is a mineral that occurs naturally and is often found in volcanic ash that has been altered by weathering and ground water. Erionite forms brittle, wool-like fibrous masses in the hollows of rock formations. Its color varies from white to clear, and it looks like transparent, glass-like fibers.

With similar properties to asbestos, erionite may pose health risks to those who breathe in the fibers. Erionite exposure has been associated with an unprecedented mesothelioma incidence in some Turkish villages in Cappadocia, and it has been widely believed that exposure to erionite was limited to that part of the world.

Erionite deposits are present in several parts of the U.S., including California, Oregon, North Dakota, South Dakota, Arizona and Nevada. In North Dakota in particular, researchers have found that more than 300 miles of roads were paved with erionite-contaminated gravel over the last 30 years.

In this study, funded through NCI PO-1 "Pathogenesis of Mesothelioma" and a AACR Landon Innovator Award for International Cancer Research, international researchers from the U.S., Italy and Turkey sought to examine the potential health risks for those exposed to erionite by comparing air samples, microchemistry, tissue samples and other data from North Dakota with those found in affected parts of Turkey.

"Based on the results of our study and considering the known latency period for lung disease, there is concern for increased risk of mesothelioma for exposed residents in North Dakota," Michele Carbone, M.D., Ph.D., lead author of the study and director of thoracic oncology at the University of Hawaii Cancer Center in Honolulu, said. "Precautionary measures should be undertaken to reduce exposure of erionite that is occurring in North Dakota and may be occurring in other areas of the U.S. where large deposits of erionite are present if disturbed. Our findings provide an opportunity to implement novel preventive and early detection programs in the U.S., similar to what has been done in Turkey."
-end-
The abstract "Erionite Exposure in North Dakota is Comparable to That Found in Turkish Villages Which Experience a High Incidence of Mesothelioma" will be presented at 4:30 p.m. Central time on December 9, 2010. To speak with Michele Carbone, M.D., Ph.D., please call Beth Bukata or Nicole Napoli on December 9-10, 2010, in the press office, the Astoria Room, at the Hilton Chicago at 312-294-6736. You may also e-mail them at bethb@astro.org or nicolen@astro.org.

American Society for Radiation Oncology

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.